Sinopharm is most used vaccine in Jordan, Pfizer most coveted: study

Jordan

Published: 2021-07-05 15:15

Last Updated: 2021-11-27 10:26


Sinopharm is most used vaccine in Jordan, Pfizer most coveted: study
Sinopharm is most used vaccine in Jordan, Pfizer most coveted: study

The Joint Chiefs of Staff - the Arab Army and the Ministry of Digital Economy and Entrepreneurship conducted the third update to the study on the effectiveness of vaccines in Jordan.

According to the study, 282,355 people have received the first dose of AstraZeneca, and 9,516 have received both doses. 852,911 have received the first dose of Pfizer, the most coveted vaccine in Jordan, and about 449,931 people have received both doses.

But the most used vaccine in the Kingdom is Sinopharm, with about 1,367,514 people having received the first dose and 833,592 having received both doses.

This brings the total number of people who received their first dose to 2,512,496 and 1,436,152 for both doses.

The number of people having contracted COVID-19 after receiving their first dose is only 19,024 out of the 3,948,648 having been vaccinated. The distribution of COVID-19 cases after being vaccinated is as follows:

AstraZeneca: 4,652
Sputnik: 110
Sinopharm: 7,661
Pfizer: 6,601

If one were to contract COVID-19 after being vaccinated, it would be on average 18 days after getting the vaccine for AstraZeneca, and 25 days after for Pfizer, Sputnik and Sinopharm.

The Adviser to the Chairman of the Joint Chiefs of Staff for Medical Affairs Dr. Adel Al Huadna said that the target for vaccination is now 6.5 million citizens. So far, 35 percent have received the first dose and 22 percent have received the second dose.

He also said that the rate of infection after the first dose is 0.005 percent and 0.003 percent after the second. 

This third update to the study was conducted after the appearance of the Delta variant. According to the study, it is clear that all who have been affected with this variant either weren’t vaccinated or only received the first dose.

In addition, Dr. Adel also stressed that the vaccines available in Jordan are highly effective and have clearly and significantly contributed to reducing the spread of the virus, just yesterday the contagiousness rate was slightly below 1.

He added that this effectiveness is even greater if people continue to practice social distancing, even for the fully vaccinated, especially in closed and crowded areas. 

When comparing the four available vaccines in Jordan with each other according to efficacy, the difference was not statistically significant.